Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Johnson And Johnson's Business Segments
Johnson And Johnson's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Innovative Medicine
Total Revenue
$ 25,310
Regions Reported
2
Revenue Share by Reportable Segment - Q2 FY2026
- Innovative Medicine64.7%
- MEDTECH35.3%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Innovative Medicine | $ 16,384 | 64.7% |
| MEDTECH | $ 8,926 | 35.3% |
Revenue Share by Region - Q2 FY2026
- Europe22.6%
- Asia-Pacific, Africa14.8%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 5,726 | 22.6% |
| Asia-Pacific, Africa | $ 3,742 | 14.8% |
Revenue by Product & Service Category - Q2 FY2026
- Darzalex16.6%
- Tremfya8.1%
- General5.8%
- Advanced4.7%
- Contact Lenses/other4%
- Invega Sustenna/xeplion/trinza/trevicta4%
- Erleada3.9%
- Trauma3.3%
- Stelara2.9%
- Spine & Other2.9%
- Xarelto2.6%
- Carvykti2.6%
- Simponi/Simponi Aria2.4%
- Opsumit/opsynvi2.4%
- Imbruvica2.4%
- Spravato2.3%
- Uptravi2%
- HIPS1.7%
- Surgical1.7%
- Knees1.6%
- Prezista/prezcobix/rezolsta/symtuza1.5%
- Caplyta1.4%
- EDURANT/rilpivirine1.4%
- REMICADE1.3%
- Rybrevant + Lazcluze1.1%
- Tecvayli1%
- Other Neuroscience0.9%
- Other Oncology0.9%
- Talvey0.7%
- CONCERTA/Methylphenidate0.6%
- Other Immunology0.4%
- Other0.2%
- Other Infectious Diseases0.2%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Darzalex | $ 4,207 | 16.6% |
| Tremfya | $ 2,046 | 8.1% |
| General | $ 1,464 | 5.8% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
30 more categories available
Sign in to unlock the full Johnson And Johnson dataset.
Description of Johnson And Johnson
Johnson & Johnson Overview
Founded in 1887 in New Brunswick, New Jersey, Johnson & Johnson has grown into a global leader in healthcare and consumer products. With a workforce of approximately 110,600 employees, the company operates more than 200 subsidiaries globally, conducting business in virtually every country around the world. The organization is dedicated to improving human health and well-being, a core principle that has guided its expansive portfolio throughout its history.
Organizational Structure
Johnson & Johnson employs a decentralized management approach, allowing each of its business segments to operate with a degree of autonomy while remaining aligned with the companys overarching mission. The Executive Committee, the principal management body, focuses on overseeing three main business segments: Consumer Health, Pharmaceutical, and Medical Devices and Diagnostics. This committee ensures efficient allocation of resources, strategic oversight, and coordination among the different sectors. The company places significant emphasis on local leadership, with each subsidiary frequently led by citizens of the host country, thereby fostering a deeper understanding of local markets and customer needs.
Business Segmentation
1. Consumer Health:
The Consumer segment of Johnson & Johnson encompasses an array of everyday health products designed for various demographics. This segment includes:
- Baby and Child Care: Featuring well-known brands like Johnsons Baby, which offers skincare products, shampoos, and other essentials for infants.
- Skin and Wound Care: Products such as Band-Aid adhesive bandages and Neutrogena skincare range fall under this category.
- Oral Care: The segment includes well-recognized oral hygiene brands like Listerine and Reach.
- Womens Health: This includes a variety of products aimed at female-specific health needs.
- Nutritional and OTC Pharmaceuticals: Over-the-counter solutions for common ailments.
2. Pharmaceutical:
The Pharmaceutical sector represents a substantial part of Johnson & Johnsons business, focusing on a diverse range of therapeutic areas aimed at serious health conditions. Key therapeutic categories include:
- Oncology: Developing and marketing drugs for various types of cancer.
- Immunology: Advanced treatments for disorders like rheumatoid arthritis and ulcerative colitis.
- Neuroscience: Addressing conditions such as schizophrenia and depression.
- Infectious Diseases: Including antibiotics and antifungals for treating infections.
- Cardiovascular Health: Medications aimed at hypertension and other heart-related issues.
The Pharmaceutical segment is notable for its focus on research and development, aiming to innovate and deliver groundbreaking therapies.
3. Medical Devices and Diagnostics:
Johnson & Johnsons Medical Devices and Diagnostics segment provides a wide range of products essential to healthcare providers and their patients. This division includes:
- Surgical Products: Instruments and tools used by surgeons in both elective and emergency procedures.
- Interventional Solutions: Devices for cardiovascular interventions, including stents and catheters.
- Orthopedics: Joint reconstruction products, trauma devices, and specialty surgical solutions.
- Diagnostic Equipment: Tests and tools used in laboratories and medical practices for disease detection and management.
International Operations
Johnson & Johnsons international presence is significant, with subsidiaries operating in 56 countries outside the United States, translating to global reach in product sales and market adaptations. This worldwide network allows the company to better understand regional health challenges and consumer behaviors, tailoring its offerings accordingly.
Competitive Landscape
Johnson & Johnson faces strong competition across all its product lines from various companies, both large and small, in the United States and globally. The competition is particularly fierce in research and product development, where new and improved products continually arise, influencing market dynamics. Johnson & Johnson invests significantly in innovation to maintain its competitive edge and to counteract potential product obsolescence. This commitment to R&D is critical across all sectors, underpinning the companys long-term success and reputation in the healthcare industry.
Recent Developments and Innovation
As of late 2023, Johnson & Johnson continues to leverage new technologies and data analytics to enhance product development and operational efficiency. The company is increasingly focusing on sustainability initiatives within its product lines, reflecting global trends towards environmental responsibility and consumer demand for greener products. Furthermore, Johnson & Johnson is actively exploring partnerships and collaborations in biopharmaceuticals and digital health solutions, indicating a strategic pivot toward integrated healthcare solutions to address contemporary health challenges.
Conclusion
In summary, Johnson & Johnson remains a cornerstone of the global healthcare landscape, with a rich history marked by innovation, a diverse product portfolio, and a committed workforce. The company’s decentralized management structure, coupled with its emphasis on local leadership and global reach, positions it well for ongoing success and responsiveness in an ever-changing market.
Founded in 1887 in New Brunswick, New Jersey, Johnson & Johnson has grown into a global leader in healthcare and consumer products. With a workforce of approximately 110,600 employees, the company operates more than 200 subsidiaries globally, conducting business in virtually every country around the world. The organization is dedicated to improving human health and well-being, a core principle that has guided its expansive portfolio throughout its history.
Organizational Structure
Johnson & Johnson employs a decentralized management approach, allowing each of its business segments to operate with a degree of autonomy while remaining aligned with the companys overarching mission. The Executive Committee, the principal management body, focuses on overseeing three main business segments: Consumer Health, Pharmaceutical, and Medical Devices and Diagnostics. This committee ensures efficient allocation of resources, strategic oversight, and coordination among the different sectors. The company places significant emphasis on local leadership, with each subsidiary frequently led by citizens of the host country, thereby fostering a deeper understanding of local markets and customer needs.
Business Segmentation
1. Consumer Health:
The Consumer segment of Johnson & Johnson encompasses an array of everyday health products designed for various demographics. This segment includes:
- Baby and Child Care: Featuring well-known brands like Johnsons Baby, which offers skincare products, shampoos, and other essentials for infants.
- Skin and Wound Care: Products such as Band-Aid adhesive bandages and Neutrogena skincare range fall under this category.
- Oral Care: The segment includes well-recognized oral hygiene brands like Listerine and Reach.
- Womens Health: This includes a variety of products aimed at female-specific health needs.
- Nutritional and OTC Pharmaceuticals: Over-the-counter solutions for common ailments.
2. Pharmaceutical:
The Pharmaceutical sector represents a substantial part of Johnson & Johnsons business, focusing on a diverse range of therapeutic areas aimed at serious health conditions. Key therapeutic categories include:
- Oncology: Developing and marketing drugs for various types of cancer.
- Immunology: Advanced treatments for disorders like rheumatoid arthritis and ulcerative colitis.
- Neuroscience: Addressing conditions such as schizophrenia and depression.
- Infectious Diseases: Including antibiotics and antifungals for treating infections.
- Cardiovascular Health: Medications aimed at hypertension and other heart-related issues.
The Pharmaceutical segment is notable for its focus on research and development, aiming to innovate and deliver groundbreaking therapies.
3. Medical Devices and Diagnostics:
Johnson & Johnsons Medical Devices and Diagnostics segment provides a wide range of products essential to healthcare providers and their patients. This division includes:
- Surgical Products: Instruments and tools used by surgeons in both elective and emergency procedures.
- Interventional Solutions: Devices for cardiovascular interventions, including stents and catheters.
- Orthopedics: Joint reconstruction products, trauma devices, and specialty surgical solutions.
- Diagnostic Equipment: Tests and tools used in laboratories and medical practices for disease detection and management.
International Operations
Johnson & Johnsons international presence is significant, with subsidiaries operating in 56 countries outside the United States, translating to global reach in product sales and market adaptations. This worldwide network allows the company to better understand regional health challenges and consumer behaviors, tailoring its offerings accordingly.
Competitive Landscape
Johnson & Johnson faces strong competition across all its product lines from various companies, both large and small, in the United States and globally. The competition is particularly fierce in research and product development, where new and improved products continually arise, influencing market dynamics. Johnson & Johnson invests significantly in innovation to maintain its competitive edge and to counteract potential product obsolescence. This commitment to R&D is critical across all sectors, underpinning the companys long-term success and reputation in the healthcare industry.
Recent Developments and Innovation
As of late 2023, Johnson & Johnson continues to leverage new technologies and data analytics to enhance product development and operational efficiency. The company is increasingly focusing on sustainability initiatives within its product lines, reflecting global trends towards environmental responsibility and consumer demand for greener products. Furthermore, Johnson & Johnson is actively exploring partnerships and collaborations in biopharmaceuticals and digital health solutions, indicating a strategic pivot toward integrated healthcare solutions to address contemporary health challenges.
Conclusion
In summary, Johnson & Johnson remains a cornerstone of the global healthcare landscape, with a rich history marked by innovation, a diverse product portfolio, and a committed workforce. The company’s decentralized management structure, coupled with its emphasis on local leadership and global reach, positions it well for ongoing success and responsiveness in an ever-changing market.
Johnson & Johnson: Comprehensive Overview of Segments, Products, and Services
Johnson & Johnson (J&J) is a renowned global healthcare company that operates across various sectors, each vital to addressing specific health concerns and consumer needs. The organization is divided into three principal segments: Consumer Health, Pharmaceutical, and Medical Devices and Diagnostics. Below is an extensive overview of these segments, along with the products and services within each.
1. Consumer Health
The Consumer Health segment comprises a broad range of products aimed at enhancing everyday health and wellness. This division produces well-known, trusted brands that cover multiple categories for consumers:
- Baby and Child Care: Products developed to ensure the safety and gentleness needed for infants and children.
- Key Brands:
- JOHNSONS® Baby: Includes a variety of baby shampoos, lotions, and wipes designed to be mild and gentle on skin.
- AVEENO® Baby: Offers moisturizers and bath products made from natural ingredients to soothe delicate skin.
- Skin and Hair Care: This subcategory addresses beauty and skincare needs, offering a range of products suitable for different skin types and concerns.
- Key Brands:
- NEUTROGENA®: Provides a wide selection of cleansers, moisturizers, and sunscreens known for their efficacy in treating various skin issues.
- AVEENO®: Focuses on naturally-derived skincare products that cater to various skin conditions and types.
- Oral Care: Aimed at promoting oral hygiene and overall health with effective dental care products.
- Key Brands:
- LISTERINE®: Offers a variety of mouthwashes designed to kill germs and promote oral health.
- REACH®: Produces toothbrushes and dental floss to help maintain healthy teeth and gums.
- Wound Care: Encompassed in this category are essential products for first aid and treating injuries.
- Key Brands:
- BAND-AID® Brand Adhesive Bandages: Available in various styles and sizes to cater to different wound care needs.
- Women’s Health Care: This segment specifically addresses products for women’s health requirements.
- Key Brands:
- CAREFREE®: Produces panty liners for everyday protection.
- STAYFREE®: Offers a range of sanitary protection products.
- Nutritionals and Over-the-Counter Pharmaceuticals: This segment includes vitamins, dietary supplements, and over-the-counter medications designed for common ailments.
- Key Brands:
- TYLENOL®: A popular pain reliever with acetaminophen.
- MOTRIN®: An ibuprofen-based anti-inflammatory and pain reliever.
- SPLENDA®: A zero-calorie sweetener for those looking for sugar alternatives.
These products are made available through various channels, including direct-to-consumer sales, retail distribution, and partnerships with wholesalers worldwide.
Pharmaceutical
The Pharmaceutical segment underlines Johnson & Johnsons commitment to innovation in drug development, focusing on several key therapeutic areas:
- Key Therapeutic Areas:
- Anti-infective: Medications targeting infections caused by bacteria or viruses, showcasing advancements in treatment options.
- Oncology: Products dedicated to cancer treatment, which includes targeted therapies and chemotherapies to combat different cancer types.
- Immunology: A portfolio of treatments for autoimmune diseases and inflammatory conditions, providing options for chronic management.
- Neurology: Solutions addressing mental health and neurological disorders, signifying a commitment to brain health.
- Pain Management: Drugs formulated to alleviate pain and enhance the quality of life for patients with chronic pain conditions.
- Notable Products:
- REMICADE® (infliximab): A biologic medication for conditions like rheumatoid arthritis and Crohn’s disease.
- PROCRIT® (Epoetin alfa): Stimulates red blood cell production, specifically for anemia management.
- LEVAQUIN® (levofloxacin): A broad-spectrum antibiotic effective against bacterial infections.
- DARZALEX® (daratumumab): A monoclonal antibody used in the treatment of multiple myeloma.
- INVEGA® (paliperidone): Approved for schizophrenia and schizoaffective disorder treatments.
The Pharmaceutical division navigates complex regulatory environments and engages with healthcare professionals to ensure effective distribution of its prescription medications through direct supply chains.
Medical Devices and Diagnostics
The Medical Devices and Diagnostics segment encompasses a comprehensive lineup of products utilized in surgical and diagnostic applications, catering to healthcare settings such as hospitals and outpatient clinics.
- Key Categories:
- Wound Care and Surgical Solutions: High-quality products for both surgical procedures and post-operative care.
- Key Brands:
- Ethicon®: Known for surgical sutures, staplers, and other surgical instruments.
- Orthopaedics: Solutions designed for joint reconstruction and supportive technologies promoting spine health.
- Key Brands:
- DePuy Synthes®: Offers a range of orthopedic implants and instruments tailored for various surgical applications.
- Cardiovascular Products: Equipment targeting heart disease management through advanced medical technologies.
- Key Brands:
- Cordis®: Provides vascular intervention products and diagnostics for cardiac health.
- Diabetes Care: Systems for blood glucose monitoring designed specifically for diabetic patients.
- Key Brands:
- LifeScan®: Known for its OneTouch® line of blood glucose monitoring systems.
- Diagnostics: Testing solutions focused on laboratory and point-of-care diagnostics essential for effective patient management.
- Key Brands:
- Ortho Clinical Diagnostics®: Producing a range of immunodiagnostic products necessary for disease detection and management.
Each product line is crafted with precision and backed by rigorous clinical research, ensuring reliability and efficacy. Distribution for medical devices is typically accomplished through partnerships with medical supply distributors and direct channels to healthcare institutions.
Conclusion
Johnson & Johnson consolidates its extensive portfolio through strategic segmentation, encompassing consumer health products, pharmaceuticals, and high-quality medical devices. With an unwavering commitment to innovation and quality, J&J continually addresses the evolving healthcare needs of both consumers and professionals, securing its position as a cornerstone of the global healthcare market. Through its comprehensive range of products and services, the company remains dedicated to improving health outcomes for people worldwide.
Johnson & Johnson (J&J) is a renowned global healthcare company that operates across various sectors, each vital to addressing specific health concerns and consumer needs. The organization is divided into three principal segments: Consumer Health, Pharmaceutical, and Medical Devices and Diagnostics. Below is an extensive overview of these segments, along with the products and services within each.
1. Consumer Health
The Consumer Health segment comprises a broad range of products aimed at enhancing everyday health and wellness. This division produces well-known, trusted brands that cover multiple categories for consumers:
- Baby and Child Care: Products developed to ensure the safety and gentleness needed for infants and children.
- Key Brands:
- JOHNSONS® Baby: Includes a variety of baby shampoos, lotions, and wipes designed to be mild and gentle on skin.
- AVEENO® Baby: Offers moisturizers and bath products made from natural ingredients to soothe delicate skin.
- Skin and Hair Care: This subcategory addresses beauty and skincare needs, offering a range of products suitable for different skin types and concerns.
- Key Brands:
- NEUTROGENA®: Provides a wide selection of cleansers, moisturizers, and sunscreens known for their efficacy in treating various skin issues.
- AVEENO®: Focuses on naturally-derived skincare products that cater to various skin conditions and types.
- Oral Care: Aimed at promoting oral hygiene and overall health with effective dental care products.
- Key Brands:
- LISTERINE®: Offers a variety of mouthwashes designed to kill germs and promote oral health.
- REACH®: Produces toothbrushes and dental floss to help maintain healthy teeth and gums.
- Wound Care: Encompassed in this category are essential products for first aid and treating injuries.
- Key Brands:
- BAND-AID® Brand Adhesive Bandages: Available in various styles and sizes to cater to different wound care needs.
- Women’s Health Care: This segment specifically addresses products for women’s health requirements.
- Key Brands:
- CAREFREE®: Produces panty liners for everyday protection.
- STAYFREE®: Offers a range of sanitary protection products.
- Nutritionals and Over-the-Counter Pharmaceuticals: This segment includes vitamins, dietary supplements, and over-the-counter medications designed for common ailments.
- Key Brands:
- TYLENOL®: A popular pain reliever with acetaminophen.
- MOTRIN®: An ibuprofen-based anti-inflammatory and pain reliever.
- SPLENDA®: A zero-calorie sweetener for those looking for sugar alternatives.
These products are made available through various channels, including direct-to-consumer sales, retail distribution, and partnerships with wholesalers worldwide.
Pharmaceutical
The Pharmaceutical segment underlines Johnson & Johnsons commitment to innovation in drug development, focusing on several key therapeutic areas:
- Key Therapeutic Areas:
- Anti-infective: Medications targeting infections caused by bacteria or viruses, showcasing advancements in treatment options.
- Oncology: Products dedicated to cancer treatment, which includes targeted therapies and chemotherapies to combat different cancer types.
- Immunology: A portfolio of treatments for autoimmune diseases and inflammatory conditions, providing options for chronic management.
- Neurology: Solutions addressing mental health and neurological disorders, signifying a commitment to brain health.
- Pain Management: Drugs formulated to alleviate pain and enhance the quality of life for patients with chronic pain conditions.
- Notable Products:
- REMICADE® (infliximab): A biologic medication for conditions like rheumatoid arthritis and Crohn’s disease.
- PROCRIT® (Epoetin alfa): Stimulates red blood cell production, specifically for anemia management.
- LEVAQUIN® (levofloxacin): A broad-spectrum antibiotic effective against bacterial infections.
- DARZALEX® (daratumumab): A monoclonal antibody used in the treatment of multiple myeloma.
- INVEGA® (paliperidone): Approved for schizophrenia and schizoaffective disorder treatments.
The Pharmaceutical division navigates complex regulatory environments and engages with healthcare professionals to ensure effective distribution of its prescription medications through direct supply chains.
Medical Devices and Diagnostics
The Medical Devices and Diagnostics segment encompasses a comprehensive lineup of products utilized in surgical and diagnostic applications, catering to healthcare settings such as hospitals and outpatient clinics.
- Key Categories:
- Wound Care and Surgical Solutions: High-quality products for both surgical procedures and post-operative care.
- Key Brands:
- Ethicon®: Known for surgical sutures, staplers, and other surgical instruments.
- Orthopaedics: Solutions designed for joint reconstruction and supportive technologies promoting spine health.
- Key Brands:
- DePuy Synthes®: Offers a range of orthopedic implants and instruments tailored for various surgical applications.
- Cardiovascular Products: Equipment targeting heart disease management through advanced medical technologies.
- Key Brands:
- Cordis®: Provides vascular intervention products and diagnostics for cardiac health.
- Diabetes Care: Systems for blood glucose monitoring designed specifically for diabetic patients.
- Key Brands:
- LifeScan®: Known for its OneTouch® line of blood glucose monitoring systems.
- Diagnostics: Testing solutions focused on laboratory and point-of-care diagnostics essential for effective patient management.
- Key Brands:
- Ortho Clinical Diagnostics®: Producing a range of immunodiagnostic products necessary for disease detection and management.
Each product line is crafted with precision and backed by rigorous clinical research, ensuring reliability and efficacy. Distribution for medical devices is typically accomplished through partnerships with medical supply distributors and direct channels to healthcare institutions.
Conclusion
Johnson & Johnson consolidates its extensive portfolio through strategic segmentation, encompassing consumer health products, pharmaceuticals, and high-quality medical devices. With an unwavering commitment to innovation and quality, J&J continually addresses the evolving healthcare needs of both consumers and professionals, securing its position as a cornerstone of the global healthcare market. Through its comprehensive range of products and services, the company remains dedicated to improving health outcomes for people worldwide.
